Status:
UNKNOWN
Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data
Lead Sponsor:
Yu Yao, MD
Conditions:
Transcriptomics
Radiomics
Eligibility:
All Genders
18-80 years
Brief Summary
This project intends to use multiple types of biological samples from glioma patients and mouse intracranial tumor models as research objects, and comprehensively apply a series of omics sequencing te...
Detailed Description
1. Through high-throughput sequencing technologies such as， genome sequencing, transcriptome sequencing and single-cell sequencing, Proteomics，Metabonomics and Metagenomics， the similarities and diffe...
Eligibility Criteria
Inclusion
- The patients with glioma in the Department of Neurosurgery of Huashan Hospital Affiliated to Fudan University who meet the following three conditions can be enrolled
- They were 18-80 years old, male and female;
- The pathological diagnosis was glioma;
- On the basis of not affecting the clinical routine diagnosis, tissue (6 mm \* 6 mm) or paraffin section (5 pieces) can be used for research;
- Sign informed consent or ethics committee approval
Exclusion
Key Trial Info
Start Date :
March 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04792437
Start Date
March 10 2021
End Date
September 30 2022
Last Update
March 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huashan hospital， Fudan University
Shanghai, China, 200040